EDGAR·FLOW

Senti Biosciences Holdings, Inc. — Form SCHEDULE 13D/A

Filed November 18, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A — Neutral significance 18/100
What the filing says
New Enterprise Associates 15, L.P., NEA Partners 15, L.P., and NEA 15 GP, LLC executed an agreement on November 18, 2026 to file a single Schedule 13D disclosure regarding their combined ownership of Senti Biosciences Holdings, Inc. shares. This is a procedural filing coordinating disclosure obligations under Rule 13d-1(k)(1); no specific share count or ownership percentage is stated in this exhibit-only filing.
Why this rating

Administrative filing coordinating joint 13D disclosure. No ownership stake, acquisition, transaction, or business change disclosed. Routine regulatory compliance.

View original filing on SEC.gov ↗ SNTI · stock on Yahoo Finance ↗

See more from November 18, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.